“The president has continued to improve. As with any illness, there are frequent ups and downs over the course, particularly when a patient is being so closely watched. Over the course of his illness, the president has experienced two episodes of transient drops in his oxygen saturation. We debated the reasons for this, and whether we’d even intervene. It was the determination of the team based predominantly on the timeline from the initial diagnosis that we initiate dexamethasone. I’d like to take this opportunity now, given some speculation over the course of the illness the last couple of days, update you on the course of his own illness: Thursday night into Friday morning, when I left the bedside, the president was doing well with only mild symptoms and his oxygen was in the high 90s. Late Friday morning, when I returned to the bedside, the president had a high fever
Late Friday evening, the White House announced that President Donald Trump did not need supplemental oxygen, and had started taking Remdesivir for his COVID-19.
The White House released a statement from official presidential physician, Dr. Sean P. Conley at 11:34 p.m. on Twitter from the account of press secretary Kayleigh McEnany.
“This afternoon, in consultation with specialists from Walter Reed and Johns Hopkins University, I recommended movement of the President up to Walter Reed National Military Medical Center for further monitoring. This evening I am happy to report that the President is doing very well. He is not requiring supplemental oxygen, but in consultation with specialists we have elected to initiate Remdesivir therapy. He has completed his first dose and is resting comfortably,” Conley wrote.